Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced the presentation of clinical and preclinical data in oral
presentation and discussion sessions at the 12 th
International Mesothelioma Interest Group (iMig) Conference being held
October 22-24, 2014, at the Cape Town International Conference Centre in
Cape Town, South Africa.
for Verastem Presents New Data on Mesothelioma Programs at the 12th International Mesothelioma Interest Group Meeting investment picks